These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 4696751)
1. The treatment of intermittent claudication with betapyridyl carbinol over two years. Nye ER; Macbeth WA Atherosclerosis; 1973; 17(1):95-106. PubMed ID: 4696751 [No Abstract] [Full Text] [Related]
2. [A delayed-action therapeutic agent in chronic cerebral circulatory insufficiencies]. Boudouresques J; Papy JJ; Daniel F Therapeutique; 1970 Oct; 46(8):789-92. PubMed ID: 5458910 [No Abstract] [Full Text] [Related]
3. The effect of nicotinic acid on muscle blood flow in intermittent claudication measured with xenon-133 clearance method. Broomé A; Cederlund J; Eklöf B Scand J Clin Lab Invest Suppl; 1967; 99():233-40. PubMed ID: 4862835 [No Abstract] [Full Text] [Related]
4. [Effect of nicotinate of xanthinol prolongatum on the walking distance of patients with arterial insufficiency of the lower extremities]. Joos F; Basyn M; Rocher A Acta Clin Belg; 1972; 27(5):529-47. PubMed ID: 4669777 [No Abstract] [Full Text] [Related]
5. A double-blind placebo-controlled study of Hexopal in the treatment of intermittent claudication. O'Hara J J Int Med Res; 1985; 13(6):322-7. PubMed ID: 3908186 [No Abstract] [Full Text] [Related]
6. Treatment of intermittent claudication with inositol nicotinate. Head A Practitioner; 1986 Jan; 230(1411):49-54. PubMed ID: 3513149 [No Abstract] [Full Text] [Related]
9. [Experiences with new Cosaldon forms]. Dammann C Med Klin; 1969 Feb; 64(8):344-8. PubMed ID: 5783023 [No Abstract] [Full Text] [Related]
10. [Clinical study of beta-pyridyl carbinol (Ronicol Timespan)]. Kobayashi K; Shibata M; Kato K; Kawaguchi S; Sasa R Saishin Igaku; 1969 Dec; 24(12):2530-4. PubMed ID: 5363412 [No Abstract] [Full Text] [Related]
11. The therapeutic efficacy of inositol nicotinate (Hexopal) in intermittent claudication: a controlled trial. O'Hara J; Jolly PN; Nicol CG Br J Clin Pract; 1988 Sep; 42(9):377-83. PubMed ID: 3075929 [No Abstract] [Full Text] [Related]
12. Clofibrate and niacin in coronary heart disease. JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963 [No Abstract] [Full Text] [Related]
13. [Lipid and carbohydrate metabolism in diabetics with hypercholesteremia during long-term treatment with beta-pyridylcarbinol]. Wandrey H; Geser CA; Zöllner N Med Klin; 1970 Apr; 65(14):668-76. PubMed ID: 5507801 [No Abstract] [Full Text] [Related]
14. [Action of pyrithioxine combined with a vasodilator in patients with cerebral arteriosclerosis]. Schlesinger P Rev Bras Med; 1972 Jan; 29(1):38-41. PubMed ID: 4552863 [No Abstract] [Full Text] [Related]
15. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100]. Bock KJ Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543 [No Abstract] [Full Text] [Related]
16. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Dawson DL; Cutler BS; Meissner MH; Strandness DE Circulation; 1998 Aug; 98(7):678-86. PubMed ID: 9715861 [TBL] [Abstract][Full Text] [Related]
17. Treatment of peripheral arterial insufficiency with inositoli nicotinas (Hexanicit). Hentzer E Scand J Clin Lab Invest Suppl; 1967; 99():226-32. PubMed ID: 4862834 [No Abstract] [Full Text] [Related]
18. Acute effect of a sustained release pyridyl carbinol preparation, ronicol retard, on plasma free fatty acids. Carlson LA; Orö L Acta Med Scand; 1969 Nov; 186(5):337-47. PubMed ID: 5378336 [No Abstract] [Full Text] [Related]
19. [Clinical evaluation of the therapeutic activity of the -pyridyl-carbinol ester of clofibric acid]. Silingardi V; Renzi R; Mora A; Di Prisco AU Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4704721 [No Abstract] [Full Text] [Related]